YQI/OCR Professional Development - Best Practices for IP Due Diligence for Venture Investments

Event time: 
Wednesday, February 7, 2018 - 3:00pm to 4:00pm
YQI Seminar Room - 4th Floor See map
17 Hillhouse
Event description: 

Office of Cooperative Research event - Register here

David Harburger and Lou Lieto from Wilson Sonsini Goodrich & Rosati will discuss “Best Practices for IP Due Diligence for Venture Investments.” WSGR is the premier legal advisor to technology, life sciences, and other growth enterprises worldwide.


Dr. David Harburger is an associate in the San Diego office of Wilson Sonsini Goodrich & Rosati, where his practice focuses on patent prosecution, strategic patent counseling, and intellectual property due diligence in the biotechnology and pharmaceutical industries. Having spent more than a decade conducting academic biomedical research, David has extensive familiarity with patent law issues specific to life sciences-based technologies, including biochemistry, bioenergy systems, cell signaling, diagnostics, genetics, immunology, medical devices, microbiome, synthetic biology, and large and small molecule therapeutics.

Prior to rejoining the firm in 2015, he worked for two years in a Silicon Valley-based patent litigation practice group as a patent agent and later as an associate, where he assisted in the preparation of notice letters, cease and desist letters, discovery requests, motions, briefs, and pleadings. From 2010 to 2011, he worked as a patent agent in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he filed numerous U.S. and international patent applications and successfully negotiated patent rights before the USPTO.

As a graduate student, David conducted biochemical research that investigated protein interactions required for the regulation of cell adhesion and migration. Prior to graduate school, he conducted research at Brigham & Women’s Hospital and Yale University Medical School, where he helped design novel genetic assays for the detection of uterine cancer.


Dr. Louis D. Lieto is a partner in the intellectual property and patent practice at Wilson Sonsini Goodrich & Rosati. Lou focuses on patent prosecution, strategic patent counseling, and IP due diligence in a variety of fields, including biofuels, immunotherapeutics, medical devices, pharmaceuticals, stem cells, and transgenic animals.

Lou received his Ph.D. from the University of Kentucky, where he focused on characterizing the molecular and genetic basis of hereditary disease. Subsequently, Lou completed his postdoctoral fellowship in immunology at the National Institute of Allergy and Infectious Diseases (NIAID). At NIAID, Lou conducted research in the fields of immunology and molecular biology to examine the regulation of gene expression of human immuno-regulatory receptors.

Prior to joining Wilson Sonsini Goodrich & Rosati, Lou was a patent examiner at the U.S. Patent and Trademark Office, where he examined applications for inventions encompassing several fields, including proteins, DNA vectors, nucleic acid vaccines, immune cell therapy, stem cell therapy, transgenic animals, and gene therapy.